Drug Shortage Report for NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305)
| Report ID | 68419 |
| Drug Identification Number | 02363658 |
| Brand name | NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305) |
| Common or Proper name | Haemodialysis Solution |
| Company Name | NXSTAGE MEDICAL INC |
| Market Status | DORMANT |
| Active Ingredient(s) | SODIUM LACTATE DEXTROSE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM CHLORIDE |
| Strength(s) | 176.5G 23.1G 2.13G 4.63G 1.57G 116.6G |
| Dosage form(s) | SOLUTION |
| Route of administration | DIALYSIS |
| Packaging size | 2 L of concentrate (produces 40 L of dialysate) |
| ATC code | B05ZA |
| ATC description | HEMODIALYTICS AND HEMOFILTRATES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2018-12-05 |
| Actual start date | 2019-03-31 |
| Estimated end date | Unknown |
| Actual end date | 2019-05-15 |
| Shortage status | Resolved |
| Updated date | 2019-06-11 |
| Company comments | Low market demand for 2 L size (produces 40 L of dialysate). The same dialysate formulation remains available in a 3 L size (produces 60 L of dialysate) |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 350 MERRIMACK STREET LAWRENCE, MASSACHUSETTS UNITED STATES 01843 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2019-06-11 | French | Compare |
| v9 | 2019-06-11 | English | Compare |
| v8 | 2019-02-15 | French | Compare |
| v7 | 2019-02-15 | English | Compare |
| v6 | 2018-12-06 | English | Compare |
| v5 | 2018-12-05 | French | Compare |
| v4 | 2018-12-05 | English | Compare |
| v3 | 2018-12-04 | French | Compare |
| v2 | 2018-12-04 | English | Compare |
| v1 | 2018-12-03 | English | Compare |
Showing 1 to 10 of 10